The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
44 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $20,650,461 in first-year total cost, median $454,221.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-D (06)]9
- Special Emphasis Panel[ZRG1 BBBP-X (61)]8
- Special Emphasis Panel[ZRG1 GGG-S (60)]7
- Special Emphasis Panel[ZRG1 BBBP-L (60)]5
- Special Emphasis Panel[ZRG1 BBBP-X (60)]4
Most frequent institutions
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI4
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH4
- UNIV OF NORTH CAROLINA CHAPEL HILL3
- BROAD INSTITUTE, INC.2
- MASSACHUSETTS GENERAL HOSPITAL2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | 1/2 Predicting Adult Outcomes in Bipolar Youth (PROBY)1R01MH112544-01A1 | BIRMAHER, BORIS | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $559,146 | ZRG1 |
| 2018 | 2/2-Predicting Adult Outcomes in Bipolar Youth (PROBY)1R01MH112543-01A1 | YEN, SHIRLEY | BROWN UNIVERSITY, RI | $246,964 | ZRG1 |
| 2017 | 1/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes1U01MH111661-01 | BUXBAUM, JOSEPH D. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $543,296 | ZRG1 |
| 2017 | The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes1U01MH111660-01 | DALY, MARK JOSEPH | BROAD INSTITUTE, INC., MA | $475,793 | ZRG1 |
| 2017 | 3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression1R01MH114969-01 | BUTTERS, MERYL A | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $452,360 | ZRG1 |
| 2017 | 3/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes1U01MH111658-01 | DEVLIN, BERNIE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $418,488 | ZRG1 |
| 2017 | 1/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment-resistant late-life depression1R01MH114970-01 | VOINESKOS, ARISTOTLE NICHOLAS | CENTRE FOR ADDICTION AND MENTAL HEALTH, ON | $390,177 | ZRG1 |
| 2017 | 4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression1R01MH114981-01 | LAVRETSKY, HELENNARR, KATHERINE L | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $359,548 | ZRG1 |
| 2017 | 2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.1R01MH114980-01 | BROWN, PATRICK JRUTHERFORD, BRET R | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $323,890 | ZRG1 |
| 2017 | 1/3 Community Psychosis Risk Screening: An Instrument Development Study1R01MH112613-01 | ELLMAN, LAUREN M | TEMPLE UNIV OF THE COMMONWEALTH, PA | $322,843 | ZRG1 |
| 2017 | 5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression1R01MH114966-01 | SHIMONY, JOSHUA S | WASHINGTON UNIVERSITY, MO | $305,389 | ZRG1 |
| 2017 | 4/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes1U01MH111662-01 | SANDERS, STEPHANSTATE, MATTHEW W. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $276,088 | ZRG1 |
| 2017 | 2/3 Community psychosis risk screening: An instrument development study1R01MH112545-01 | MITTAL, VIJAY A | NORTHWESTERN UNIVERSITY, IL | $234,750 | ZRG1 |
| 2017 | 3/3: Community Psychosis Risk Screening: An Instrument Development Study.1R01MH112612-01 | SCHIFFMAN, JASON E | UNIVERSITY OF MARYLAND BALTIMORE COUNTY, MD | $222,419 | ZRG1 |
| 2016 | 2/7 Psychiatric Genomics Consortium: Finding Actionable Variation1U01MH109539-01 | DALY, MARK JOSEPH | MASSACHUSETTS GENERAL HOSPITAL, MA | $849,786 | ZRG1 |
| 2016 | 7/7 Psychiatric Genomics Consortium: Finding actionable variation1U01MH109532-01 | AGRAWAL, ARPANAEDENBERG, HOWARD JGELERNTER, JOEL | WASHINGTON UNIVERSITY, MO | $695,417 | ZRG1 |
| 2016 | 5/7 Psychiatric Genomics Consortium: Finding actionable variation1U01MH109514-01 | O'DONOVAN, MICHAEL | CARDIFF UNIVERSITY | $626,109 | ZRG1 |
| 2016 | 3/7 Psychiatric Genomics Consortium: Finding actionable variation1U01MH109536-01 | SKLAR, PAMELA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $595,308 | ZRG1 |
| 2016 | 1/7 Psychiatric Genomics Consortium: Finding actionable variation1U01MH109528-01 | SULLIVAN, PATRICK F | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $478,788 | ZRG1 |
| 2016 | 1/2 Phenotype Predictors of Cognitive Outcomes in Geriatric Depression1R01MH108578-01A1 | STEFFENS, DAVID C. | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | $438,399 | ZRG1 |
| 2016 | 4/7 Psychiatric Genomics Consortium: Finding actionable variation1U01MH109501-01 | SEBAT, JONATHAN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $377,507 | ZRG1 |
| 2016 | 2/2 Phenotype Predictors of Cognitive Outcomes in Geriatric Depression1R01MH108560-01A1 | POTTER, GUY GLENN | DUKE UNIVERSITY, NC | $357,750 | ZRG1 |
| 2016 | 6/7 Psychiatric Genomics Consortium finding actionable variation1U01MH109499-01 | GILL, MICHAEL | TRINITY COLLEGE DUBLIN | $154,482 | ZRG1 |
| 2015 | 1/2 A Large-Scale Schizophrenia Association Study in Sweden2R01MH077139-07 | SULLIVAN, PATRICK F | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,171,162 | ZRG1 |
| 2015 | 2/2 Large-Scale Genetic Studies of Schizophrenia in Sweden2R01MH095034-04 | SKLAR, PAMELA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $556,787 | ZRG1 |
| 2015 | 2/2 - Familial Early-Onset Suicide Attempt Biomarkers1R01MH108032-01 | MANN, JOSEPH JOHN | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $512,237 | ZRG1 |
| 2015 | 1/3 Brain Function and Genetics in Pediatric Obsessive-Compulsive Behaviors2R01MH059299-15A1 | ROSENBERG, DAVID R | WAYNE STATE UNIVERSITY, MI | $475,873 | ZRG1 |
| 2015 | 1/3 Genetic Analysis of the International Cohort Collection for Bipolar Disorder1R01MH106531-01 | SKLAR, PAMELA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $471,010 | ZRG1 |
| 2015 | 2/2-Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth1R01MH105469-01A1 | SINGH, MANPREET K | STANFORD UNIVERSITY, CA | $435,993 | ITVA |
| 2015 | 1/2-Mechanisms of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth1R01MH105464-01A1 | DELBELLO, MELISSA P | UNIVERSITY OF CINCINNATI, OH | $355,500 | ITVA |
| 2015 | 1/2-Familial Early-Onset Suicide Attempt Biomarkers1R01MH108039-01 | BRENT, DAVID A. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $269,813 | ZRG1 |
| 2015 | 2/3 Brain Function and Genetics in Pediatric Obsessive-Compulsive Behaviors2R01MH085321-06A1 | HANNA, GREGORY L. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $232,500 | ZRG1 |
| 2015 | 2/3-Genetic Analysis of the International Cohort Collection for Bipolar Disorder1R01MH106527-01 | MCCARROLL, STEVEN ANDREW | BROAD INSTITUTE, INC., MA | $177,000 | ZRG1 |
| 2015 | 3/3 Genetic Analysis of the International Cohort Collection for Bipolar Disorder1R01MH106547-01 | SMOLLER, JORDAN W | MASSACHUSETTS GENERAL HOSPITAL, MA | $174,000 | ZRG1 |
| 2015 | 3/3 Brain Function and Genetics in Pediatric Obsessive-Compulsive Behaviors2R01MH085300-06A1 | ARNOLD, PAUL DANIELSCHERER, STEPHEN W. | HOSPITAL FOR SICK CHLDRN (TORONTO), ON | $37,779 | ZRG1 |
| 2014 | "1/9-Predictors and Mechanisms of Conversion to Psychosis2U01MH081902-06A1 | CANNON, TYRONE D | YALE UNIVERSITY, CT | $1,154,701 | ZMH1 |
| 2014 | 9/9-Predictors and Mechanisms of Conversion to Psychosis2U01MH076989-06A1 | MATHALON, DANIEL H | NORTHERN CALIFORNIA INSTITUTE/RES/EDU, CA | $818,131 | ZMH1 |
| 2014 | 3/9- Predictors and Mechanisms of Conversion to Psychosis2U01MH081928-06A1 | SEIDMAN, LARRY J | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $808,262 | ZMH1 |
| 2014 | 5/9 Predictors and Mechanisms of Conversion to Psychosis2U01MH082004-06A1 | PERKINS, DIANA O. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $686,261 | ZMH1 |
| 2014 | 2/9 - Predictors and Mechanisms of Conversion to Psychosis2U01MH081988-06A1 | WALKER, ELAINE FRAN | EMORY UNIVERSITY, GA | $553,684 | ZMH1 |
| 2014 | 6/9-Predictors and Mechanisms of Conversion to Psychosis2U01MH081944-06A1 | CADENHEAD, KRISTIN S. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $550,148 | ZMH1 |
| 2014 | 8/9 Predictors and Mechanisms of Conversion to Psychosis2U01MH082022-06A1 | WOODS, SCOTT W | YALE UNIVERSITY, CT | $538,617 | ZMH1 |
| 2014 | 4/9-Predictors and Mechanisms of Conversion to Psychosis2U01MH081857-06A1 | CORNBLATT, BARBARA A. | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $510,225 | ZMH1 |
| 2014 | "7/9" Predictors and Mechanisms of Conversion to Psychosis2U01MH081984-06A1 | ADDINGTON, JEAN M | UNIVERSITY OF CALGARY, AB | $456,081 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.